- Parties: The plaintiff was Nuvo Pharmaceuticals (Ireland) Designated Activity Company. The defendants were Pharmascience Inc. and the patent owner, Grunenthal GmbH.

- Subject Matter: This action concerned an alleged patent infringement under the Patented Medicines (Notice of Compliance) Regulations. The plaintiff sought to prevent Pharmascience Inc. from launching a generic version of a patented drug. This case is ongoing.

- Date: The hearing was set on September 2, 2025.

- Venue: This was a federal case before the Federal Court.

- Amount: No financial award was specified.